EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Anxiety and the brain: Neuropeptides as emerging factors

Kiran S Satao, Gaurav M Doshi

Pharmacology Biochemistry and Behavior · 2024

DOI: 10.1016/j.pbb.2024.173878 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacology Biochemistry and Behavior, 2024. Verfasst von Kiran S Satao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, V. M. Road, Vile Parle (W), Mumbai 400 056, Maharashtra, India. Hauptthemen laut MEDLINE: Neuropeptides, Brain, Anxiety. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 231 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anxiety disorders are characterized by intense feelings of worry and fear, which can significantly interfere with daily functioning. Current treatment options primarily include selective serotonin reuptake inhibitors, benzodiazepines, non-benzodiazepine anxiolytics, gabapentinoids, and beta-blockers. Neuropeptides have shown an important role in the regulation of complex behaviours, such as psychopathology and anxiety-related reactions. Neuropeptides have a great deal of promise to advance our understanding of and ability to help people with anxiety disorders. This review focuses on the expanding role of neuropeptides in anxiety management, particularly examining the impact of substance P, neuropeptide Y, corticotropin-releasing hormone, arginine-vasopressin, pituitary adenylate cyclase-activating polypeptide, and cholecystokinin. Furthermore, the paper discusses the neuropeptides that are becoming more and more recognized for their impact on anxiety-related reactions and their potential as therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuropeptidesBrainAnxietyHumansAnimalsPituitary Adenylate Cyclase-Activating PolypeptideAnxiety DisordersSubstance PArginine VasopressinCorticotropin-Releasing HormoneAnti-Anxiety AgentsCholecystokininNeuropeptide Y

Stichwörter der Autor:innen

AmygdalaAnxietyCorticotropin-releasing horomoneNeuropeptidesTreatment

Substanzen

NeuropeptidesPituitary Adenylate Cyclase-Activating PolypeptideSubstance PArginine VasopressinCorticotropin-Releasing HormoneAnti-Anxiety AgentsCholecystokininNeuropeptide Y

Autor:innen und Institutionen

  • Department of Pharmacology, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, V. M. Road, Vile Parle (W), Mumbai 400 056, Maharashtra, India.
  • Department of Pharmacology, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, V. M. Road, Vile Parle (W), Mumbai 400 056, Maharashtra, India. Electronic address: gaurav.pharmacology@gmail.com.

Zitieren

APA

Satao, K. S., & Doshi, G. M. (2024). Anxiety and the brain: Neuropeptides as emerging factors. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/j.pbb.2024.173878

Vancouver

Satao KS, Doshi GM. Anxiety and the brain: Neuropeptides as emerging factors. Pharmacology Biochemistry and Behavior. 2024. doi:10.1016/j.pbb.2024.173878

BibTeX
@article{Satao2024,
  author = {Satao, Kiran S and Doshi, Gaurav M},
  title = {Anxiety and the brain: Neuropeptides as emerging factors},
  journal = {Pharmacology Biochemistry and Behavior},
  year = {2024},
  doi = {10.1016/j.pbb.2024.173878}
}
Kostenlos starten →